NRAS and cancer: At least 25% of cancer drivers are inherently palmitoylated18 including multiple isoforms of the RAS GTPases protein (KRAS, HRAS and NRAS) that are the most frequently mutated oncogenes in human cancers, including in LUAD, (i.e., 30% of LUADs contain somatic KRAS mutation)1.